Related Experiment Videos
Tyrosine transport in schizophrenia
F A Wiesel1, N Venizelos, L Bjerkenstedt
1Department of Psychiatry, Uppsala University, Sweden.
Schizophrenia Research
|October 1, 1994
Summary
Schizophrenia patients show reduced tyrosine transport in skin cells, confirming previous findings. This suggests a primary cell membrane dysfunction, not directly influenced by common psychotropic drugs or receptor mechanisms.
Area of Science:
- Neuroscience
- Cell Biology
- Psychiatry
Background:
- Schizophrenia is a complex psychiatric disorder with suspected underlying biological mechanisms.
- Previous research suggests alterations in amino acid transport may be involved in schizophrenia pathophysiology.
Purpose of the Study:
- To investigate tyrosine transport in cultured skin fibroblasts from individuals with schizophrenia.
- To determine if psychotropic drugs or specific receptor mechanisms influence tyrosine transport in schizophrenia.
Main Methods:
- Cultured skin fibroblasts from schizophrenia patients (DSM-III-R) and normal subjects were used.
- Tyrosine transport capacity (Vmax) was measured.
- Cells were incubated with psychotropic drugs and their transport was compared.
Main Results:
- A significantly lower tyrosine transport capacity (Vmax) was observed in fibroblasts from schizophrenia patients compared to normal subjects.
- Tyrosine transport was not differentially affected by psychotropic drug incubation between patient and control groups.
- Dopaminergic and beta-adrenergic receptor stimulation did not appear to influence tyrosine uptake.
Conclusions:
- The findings support a primary disturbance in tyrosine transport in schizophrenia.
- This deficit may indicate a generalized cell membrane dysfunction in individuals with schizophrenia.
- The results suggest that tyrosine transport alterations in schizophrenia are not directly modulated by common psychotropic medications or major neurotransmitter receptor systems.